Rhopressa-induced corneal edema: a case report

BACKGROUND: Rhopressa (netarsudil) has recently been added to the arsenal of treatment for open-angle glaucoma. It is an effective norepinephrine transporter and Rho-associated protein kinase (ROCK) inhibitor used to decrease intraocular pressure (IOP), with the most common side effect being conjunc...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Matthew J., Song, Michael, Palmares, Trisa, Song, Alice, Song, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019159/
https://www.ncbi.nlm.nih.gov/pubmed/33810801
http://dx.doi.org/10.1186/s13256-021-02665-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019159/
https://www.ncbi.nlm.nih.gov/pubmed/33810801
http://dx.doi.org/10.1186/s13256-021-02665-0

Ejemplares similares